InvestorsHub Logo
icon url

Apdn believer

08/14/13 3:51 PM

#20672 RE: Shail #20670

I do agree shail that APDN does not want to become a one trick pony. Hopefully the DLA mandate is a fantastic endorsement of our products and we will find greater success elsewhere. I do think the pharm market could be very special. Especially given the health risks of counterfeits.

Thanks for your comments I hope you get some answers to your questions tomorrow :)

GLTA



icon url

mcsharkey

08/14/13 4:24 PM

#20674 RE: Shail #20670

Yeah Shail,
I agree with your points on where is the revenue stream going to come from once customer is set up with the equipment and DNA-laced ink.

Hoping they'll talk about the money stream from established military supply accounts tomorrow:

1. Is the SigNATURE DNA database viewed as a long term
stream for funding (i.e. Site license, transaction costs,
etc.)?

2. Do startup costs of the OEM and distributor companies include
all required equipment purchased through Applied DNA Science?

3. Will processing lines be held to a maintenance licensing
agreement with Applied DNA Sciences?



Etc. Data base management and equipment maintenance contracts can be pretty lucrative.

Just my thoughts. Dunno if they're going to address 'em.
VR
mcsharkey